Feature image

What's New

Outcome of the Consultation on the Proposal to Change the Regulatory and Funding Restrictions for Stimulant Treatments for ADHD

Following public consultation with Pharmac, Medsafe has made the decision to change the regulatory restrictions on who can initiate prescribing of stimulant medicines for ADHD.

Find out more

News and Events

Date Type Title
1/7/2025CommitteesAgenda for the 126th meeting of the Medicines Assessment Advisory Committee to be held on 18 July 2025
30/6/2025CommitteesMelatonin without a prescription
24/6/2025ConsultationOutcome of the consultation on the proposal to change the regulatory and funding restrictions for stimulant treatments for ADHD
16/6/2025ConsultationTopical corticosteroids: Proposal for the package labelling to state their potency
12/6/2025NoticesMedsafe industry meetings May 2025
12/6/2025ConsultationProposed updates to the Guideline on the Regulation of Therapeutic Products in New Zealand: Bioequivalence of medicines
10/6/2025CommitteesMedicines Classification Committee - Dates and Deadlines
10/6/2025CommitteesAgenda for the 74th meeting of the Medicines Classification Committee to be held on 23 July 2025
5/6/2025PublicationsPrescriber Update Vol. 46. No. 2 - June 2025
30/5/2025Alert CommunicationStop using Euky Bear Warm Steam Vaporiser - model number EBSV2013
5/5/2025NoticesPolicy Statement - Early notification of potential medicine supply issues